01 1Defitelio
02 5Defitelio/defibrotide
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 196
2019 Revenue in Millions : 173
Growth (%) : 13
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 198
2020 Revenue in Millions : 196
Growth (%) : 1
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 194
2021 Revenue in Millions : 198
Growth (%) : -2
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 184
2022 Revenue in Millions : 194
Growth (%) : -5
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 217
2023 Revenue in Millions : 184
Growth (%) : 18
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 173
2018 Revenue in Millions : 149
Growth (%) : 16
